期刊文献+

芳氨基代-α-呋喃葡萄糖衍生物的合成及抗肿瘤活性 被引量:1

Synthesis and Anti-tumor Activities of Arylamino-α-glucofuranose Derivatives
下载PDF
导出
摘要 分别以2-甲基-5-硝基苯甲酸、2-氯-5-硝基苯甲酸为原料,经羧基氯化、Friedel-Crafts酰基化、羰基还原、硝基还原和还原胺化反应合成了4种新型的1,2-O-异丙叉基-5-芳氨基代-α-呋喃葡萄糖衍生物。利用IR、NMR和HRMS等技术手段对反应所及中间体及目标化合物进行了结构测定和表征,并采用MTT法将目标化合物对3种人体肿瘤细胞的抗肿瘤活性进行了初步评价。结果表明,目标化合物1a1对肿瘤细胞的生长抑制作用优于其它3种目标化合物,特别是对A431细胞表现出更明显的生长抑制活性(IC50:(6.54±1.34)μmol/L)。 Four novel 1,2-O-isopropylidene-5-arylamino-a-glucofuranose derivatives were prepared using 2-methyl-5-nitrobenzoicacid and 2-chloro-5-nitrobenzoic acid, respectively, as the starting materials by a synthetic route including chlorination of carboxylic acid, Friedel-Crafts acylation, reduction of carbonyl, reduction of nitro and reductive amination. The structures of intermediates and target compounds were characterized by IR, NMR and HRMS. The anti-tumor activities of target compounds on three kinds of cells were tested preliminarily by MTF method. The results indicate that the anti-tumor activitives of compound lal is better than other three kinds of target compounds on three kinds of tumor ceils, especially on A431 ( IC50 : (6. 54±1.34) μmol/L).
出处 《应用化学》 CAS CSCD 北大核心 2015年第9期987-993,共7页 Chinese Journal of Applied Chemistry
基金 国家自然科学基金资助项目(21272144)~~
关键词 芳氨基代葡萄糖衍生物 合成 抗肿瘤活性 arylaminogluofuranose derivatives synthesis anti-tumor activity
  • 相关文献

参考文献20

  • 1Shang H, Chen H,Zhao D M ,et al. Synthesis and Biological Evaluation of 4a/4fl-Imidazolyl Podophyllotoxin Analogues as Antitumor Agents [ J ]. Arch Pharm Chem Life Sci ,2012,345 (1) :43-48.
  • 2尚海,潘莉,杨澍,陈虹,程卯生.微管蛋白抑制剂的研究进展[J].药学学报,2010,45(9):1078-1088. 被引量:18
  • 3李耀武,周有骏,朱驹,郑灿辉,陈军,盛春泉,吕加国,唐辉,栗亚男,张珏.作用于秋水仙碱位点的微管蛋白抑制剂的结合模式研究与结构模型的构建[J].化学学报,2008,66(14):1735-1739. 被引量:4
  • 4任晓岚,汪鑫,李志裕,尤启冬.表皮生长因子受体(EGFR)酪氨酸激酶抑制剂的研究进展[J].中国新药杂志,2005,14(7):821-826. 被引量:31
  • 5张晓彤,李龙芸.肺癌的靶向治疗[J].中国肺癌杂志,2004,7(3):256-259. 被引量:18
  • 6Laskin J J,Sandler A B. Epidermal Growth Factor Receptor A Promising Target in Solid Tumours[ J]. Cancer Treat Rev, 2004,30(1) :1-17.
  • 7Vlahovic G, Crawford J. Activation of Tyrosine Kinases in Cancer [ J ]. O ncologist,2003,8 ( 6 ) : 531-538.
  • 8Ravaud A, Hawkins R, Gardner J P, et al. Lapatinib Versus Hormone Therapy in Patients with Advanced Renal CellCarcinoma: A Randomized Phase III Clinical Trial[ J ]. J Clin 0ncoi,2008,26 (14) :2285-2291.
  • 9Carter M C, Cockerill G S, Guntrip S B,et aL Bicyclic Heteroaromatic Compounds [ Quinazolinamines, Pyridopyri-midines, and Analogs] Useful as Protein Tyrosine Kinase Inhibitors. WO,9935146A1. [ P] , 1999-07-15.
  • 10Sato T, Watanabe H, Tsuganezawa K, et al. Identification of Novel Drug-resistant EGFR Mutant Inhibitors by I-nsilico Screening Using Comprehensive Assessments of Protein Structures[ J]. Bioorg Med Chem,2012,20(12) :3756-3767.

二级参考文献118

共引文献72

同被引文献17

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部